Gantumur D, Aikawa M, Khishigjargal T, Norov E, Ukon N, Haba H. Activation cross sections of proton- induced reactions on natural platinum up to 30 MeV. Applied Radiation and Isotopes. 202302; 192:110621.
Yamakuni R, Ishii S, Yamada S, Hara J, Suenaga H, Sugawara S, Sekino H, Yamaki T, Ishida K, Hashimoto Y, Ito H. Different prognostic outcomes in two cases of FDG-PET/CT-Positive and -negative cardiac angiosarcoma. Fukushima Journal of Medical Science. 202304; 69(1):45-49.
Eiro T, Miyazaki T, Hatano M, Nakajima W, Arisawa T, Takada Y, Kimura K, Sano A, Nakano K, Mihara T, Takayama Y, Ikegaya N, Iwasaki M, Hishimoto A, Noda Y, Miyazaki T, Uchida H, Tani H, Nagai N, Koizumi T, Nakajima S, Miura M, Matsuda N, Kanai K, Takahashi K, Ito H, Hirano Y, Kimura Y, Mastumoto R, Ikeda A, Takahashi T. Dynamics of AMPA receptors regulate epileptogenesis in patients with epilepsy. Cell Reports Medicine. 202305; 4(5):101020.
Kitajima K, Kuyama J, Kawahara T, Suga T, Otani T, Sugawara S, Kono Y, Tamaki Y, Seko-Nitta A, Ishiwata Y, Ito K, Toriihara A, Watanabe S, Hosono M, Miyake H, Yamamoto S, Sasaki R, Narita M, Yamakado K. Assessing Therapeutic Response to Radium-223 with an Automated Bone Scan Index among Metastatic Castration-Resistant Prostate Cancer Patients: Data from Patients in the J-RAP-BSI Trial.Cancers. 202305; 15(10):2784.
Ukon N, Aikawa M, Saito M, Hagiwara M, Yashima H, Komori Y, Haba H, Takács S, Ditrói F, Szűcs Z. Activation cross sections of alpha-particle-induced reactions on natural tungsten for osmium and rhenium radionuclides. Nuclear Instruments and Methods in Physics Research, Section B. 202306; 539:95-101.
Ogawa K, Nishizawa K, Washiyama K, Munekane M, Fuchigami T, Echigo H, Mishiro K, Hirata S, Wakabayashi H, Takahashi K, Kinuya S. Astatine-211-labeled aza-vesamicol derivatives as sigma receptor ligands for targeted alpha therapy. Nuclear Medicine and Biology. 202307; 122-123:108369.
Oto M, Yamada C. Nurse Administrators’ Roles for Nurse Retention when Radioactive Disaster occurs: Findings from Nurses’ Evacuation Consideration and Evacuation after the Fukushima Daiichi Nuclear Power Plant accident. International Journal of Nursing Education. 202307;15(3):44-52.
Hotsumi H, Ishii S, Suenaga H, Sugawara S, Fukushima K, Ito H. Investigation of tumor assessment between two PET systems using various indices: comparison between PET/CT and PET/MRI systems. American Journal of Nuclear Medicine and Molecular Imaging. 202308; 13(4):156-163.
Nakahara T, Iwabuchi Y, Miyazawa R, Tonda K, Shiga T, Strauss HW, Antoniades C, Narula J, Jinzaki M. Assessment of Myocardial 18F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2-vaccinated and Nonvaccinated Patients. Radiology. 202309; 308(3):e230743.
Ogata H, Kitamura S, Fujiwara M, Shimizu M, Tan C, Zhao S, Maejima Y, Shimomura K. Dose dependent effect of Sulfamethoxazole on inhibiting KATP channel of mouse pancreatic β cell. Dose Response. 202309; 21(3):15593258231203611.
Sasaki I, Tada M, Liu Z, Tatsuta M, Okura T, Aoki M, Takahashi K, Ishioka S N, Watanabe S, Tanaka H. 1- (N,N-Dialkylcarbamoyl)-1,1-difluoromethanesulfonyl ester as a stable and effective precursor for neopentyl labeling group with astatine-211. Organic & Biomolecular Chemistry. 202309; 21(36):7467-7472.
Aikawa M, Toyoeda Y, Gantumur D, Ukon N, Ebata S, Haba H, Takács S, Ditrói F, Szűcs Z. Activation cross sections of deuteron-induced reactions on natural rhenium up to 23 MeV. Nuclear Instruments and Methods in Physics Research, Section B. 202310; 543:165093.
Echigo H, Mishiro K, Munekane M, Fuchigami T, Washiyama K, Takahashi K, Kitamura Y, Wakabayashi H, Kinuya S, Ogawa K. Development of probes for radiotheranostics with albumin binding moiety to increase the therapeutic effects of astatine-211 (211At). European Journal of Nuclear Medicine and Molecular Imaging. 202310; 512(2):412-421.
Fukushima K, Endo K, Yamakuni R, Kiko T, Sekino H, Kikori K, Ukon N, Ishii S, Yamaki T, Ito H, TakeishiY. Simultaneous assessment of left ventricular mechanical dyssynchrony using integrated 13N-ammonia PETMR system: direct comparison of PET phase analysis and MR feature tracking. Journal of Nuclear Cardiology. 202310; 30(5):1947-1958.
Ito H, Ibaraki M, Yamakuni R, Hakozaki M, Ukon N, Ishii S, Fukushima K, Kubo H, Takahashi K. Oxygen extraction fraction is not uniform in human brain: a positron emission tomography study. Journal of Physiological Sciences. 202310; 73(1):25.
Shin Y, Maruyama S, Kawasaki K, Aoi K, Washiyama K, Nishinaka I, Yano S, Haba H, Yokoyama A. Solvent extraction following oxidation of astatine for the use of a 211Rn–211At generator. Journal of Radioanalytical and Nuclear Chemistry. 202312; 333:403-409.
Tonda K, Iwabuchi Y, Shiga T, Owaki Y, Fujita A, Nakahara T, Sakurai R, Shimizu A, Yamada Y, Okada M, Jinzaki M. Impact of patient characteristic factors on the dynamics of liver glucose metabolism: Evaluation of multiparametric imaging with dynamic whole-body 18F-fluorodeoxyglucose-positron emission tomography. Diabetes, Obesity & Metabolism. 202312; 25(12):3521-3528.
Zhao J, Nan G, Zhao S. Endovascular thrombectomy prior to decompressive craniectomy in acute ischemic stroke with low ASPECTS. Kuwait Medical Journal. 202312; 55(4):343-348.
右近直之. 【2024 年の核医学TOPICS!】核医学治療における線量評価について. Rad Fan. 202312; 22(1):29-32.
菅原茂耕. 【2024 年の核医学TOPICS!】アルファ線治療と211At-MABG. Rad Fan. 202312; 22(1):38-42.
[Review Articles]
Fukushima K, Ito H, Takeishi Y. Comprehensive assessment of molecular function, tissue characterization, and hemodynamic performance by non-invasive hybrid imaging: Potential role of cardiac PETMR. Journal of Cardiology. 202310; 82(4):286-292.
Yamakuni R, Ishii S, Yamada S, Hara J, Suenaga H, Sugawara S, Sekino H, Yamaki T, Ishida K, Hashimoto Y, Ito H. Different prognostic outcomes in two cases of FDG-PET/CT-Positive and -negative cardiac angiosarcoma. Fukushima Journal of Medical Science. 202304; 69(1):45-49.
Sakashita T, Ukon N, Higashi T. Dosimetry in therapy using radiopharmaceuticals. In: Shirai T, Nishio T, Sato K. Advances in Accelerators and Medical Physics. Amsterdam: Academic Press; 2023. p.315-325.
Washiyama K, Sugiyama A, Zhao S, Tatsumi T, Aoki M, Yamatsugu K, Nishijima K, Ukon N, Shimoyama S, Joho T, Oriuchi N, Kanai M, Takahashi K, Kodama T. Pretargeted alpha radioimmunotherapy for the treatment of gastric cancer using low-immunogenic mutated streptavidin and 211At labeled modified bis-iminobiotin. TAT12 International Symposium; 20230227-0302; Cape Town, South Africa.
Endo K, Katahira M, Fukushima K, Takeishi Y. Prognostic Value of Simultaneous Analysis with Myocardial Flow Reserve and Right Ventricular Strain by 13N-ammonia Positron Emission Tomography/Magnetic Resonance Imaging.第87 回日本循環器学会学術集会; 20230310-12; 福岡.
Echigo H, Mishiro K, Washiyama K, Fuchigami T, Munekane M, Takahashi K, Kunishima M, Kinuya S, Ogawa K. Development of a radiotheranostics agent with albumin binder aiming to increase the therapeutic effects for At-211 labeled RGD peptide. 25th International Symposium on Radiopharmaceutical Sciences; 20230522-26; Honolulu, USA.
Yamashita T, Hirayama M, Yasuda T, Kaizuka Y, Takahashi K, Kannaka K, Suzuki H, Uehara T. Development of radio-halogen-labeled PSMA-targeting ligand with high in vivo stability. 25th International Symposium on Radiopharmaceutical Sciences; 20230522-26; Honolulu, USA.
Fukushima K, Katahira M, Endo K, Yamakuni R, Kiko T, Ukon N, Ishii S, Yamaki T, Ito H, Takeishi Y. Discrepancy of Stress-Induced Left Ventricular Dilation Between Positron Emission Tomography and Cardiac Magnetic Resonance in Patients with Coronary Artery Disease -Simultaneous assessment using integrated PETMR system-. Annual Meeting 2023: Society of Nuclear Medicine; 20230624-27; Chicago, USA.
Fukushima K, Katahira M, Endo K, Yamakuni R, Kiko T, Ukon N, Ishii S, Yamaki T, Ito H, Takeishi Y. Novel analysis for endocardial wall strain with N-13 ammonia PET feature tracking -Comparison with CMR-feature tracking using integrated PETMR system-. Annual Meeting 2023: Society of Nuclear Medicine; 20230624-27; Chicago, USA.
Zhao S, Ukon N, Shimoyama S, Zhao J, Joho T, Nishijima K, Washiyama K, Takahashi K, Kobayakawa M, Shiga T, Oriuchi N, Ito H. Possibility of 123I-meta-iodobenzylguanidine (MIBG) as companion diagnostic drug for therapeutic alpha-emitting meta-211At-astato-benzylguanidine (211At-MABG) in normal and pheocheomocytoma xenograft mice. Annual Meeting 2023: Society of Nuclear Medicine; 20230624-27; Chicago, USA.
Zhao S, Ukon N, Shimoyama S, Zhao J, Joho T, Nishijima K, Washiyama K, Takahashi K, Kobayakawa M, Shiga T, Oriuchi N, Ito H. Possibility of 123I-meta-iodobenzylguanidine (MIBG) as companion diagnostic drug for therapeutic alpha-emitting meta-211At-astato-benzylguanidine (211At-MABG) in normal and pheocheomocytoma xenograft mice. SNMMI 2023 Annual Meeting; 20230626; Chicago, USA. Journal of Nuclear Medicine. 64(Supplement 1):74.
Miyaji N, Miwa K, Yamashita K, Yamao T, Oriuchi N, Terauchi T. Comparison of MIRD based- and Monte Carlo simulation based patient-specific dosimetry in 177Lu-DOTATATE. EANM’23. 20230909-13, Viena, Austria
Fukushima K, Katahira M, Endo K, Yamakuni R, Kiko T, Ukon N, Shimizu T, Ishii S, Yamaki T, Ito H, Takeishi Y. Clinical Usefulness of Myocardial Wall Strain Analysis by PET Feature Tracking: Direct Comparison With Conventional Tagging-Cine Image Using PETMR System. American Society of Nuclear Cardiology 2023 Annual Meeting; 20230929-1001; Toronto, Canada.
Fukushima K, Katahira M, Endo K, Yamakuni R, Kiko T, Ukon N, Shimizu T, Ishii S, Yamaki T, Ito H, Takeishi Y. Simultaneous Assessment of Coronary Sinus Flow and Myocardial Flow Reserve Under Pharmacological Stress Using Hybrid 13N-ammonia PETMR System in Patients with Ischemic Heart Disease. American Society of Nuclear Cardiology 2023 Annual Meeting; 20230929-1001; Toronto, Canada.
Endo K, Katahira M, Kiko T, Yamakuni R, Ukon N, Shimizu T, Ishii S, Yamaki T, Nakazato K, Fukushima K, Ito H, Takeishi Y. Simultaneous Analysis of Myocardial Flow Reserve and Intra-Ventricular 4D Flow Using Hybrid 13N-ammonia Positron Emission Tomography/Magnetic Resonance Imaging in Patients With Coronary Artery Disease. American Heart Association Scientific Sessions 2023; 20231111-13; Philadelphia, USA.
Ikezoe T, Tachibana T, Oriuchi N, Nishijima K, Ukon N, Shimoyama S, Joho T, Washiyama K, Takahashi K, Zhao S. Delivery of alpha-particles by a human-rat chimeric CD82 monoclonal antibody potently inhibits the proliferation of CD82-expressing acute myeloid leukemia cells in a murine xenograft model. 65th American Society of Hematology Annual Meeting & Exposition (ASH 2023); 20231211; San Diego, USA.
[Symposiums]
Zhao S. Current Status and Future Prospects of Preclinical Development of Targeted Alpha Particle Therapy using 211At at Fukushima Medical University. International Symposium on Development of Radiotheranostics in Fukushima; 20230129; 南相馬.
志賀哲. Developmnet of At-211 MABG therapy. International Symposium on Development of Radiotheranostics in Fukushima; 20230129; 南相馬.
Washiyama K. Production and use of alpha-emitting At-211 for targeted radionuclide therapy in Japan. International Symposium on Trends in Radiopharmaceuticals (ISTR-2023); 20230417-21; Vienna, Austria.
伊藤浩. PET 研修セミナー 指針と考え方2 PET 臨床研究の注意点. 第23 回日本核医学会春季大会; 20230426- 0601; Web.
Washiyama K. Astatine-211 bench to bedside, stories from Japan. IAEA Regional Technical Cooperation Project RAS6097; Enhancing Capacity and Capability for the Production of Cyclotron-Based Radiopharmaceuticals (RCA); Regional Training Course Production and Preclinical Evaluation of Emerging Cyclotron-based Radiopharmaceuticals; 20231016-20; Sydney, Australia.
Washiyama K. Current activity of Astatine network in Japan ~ toward the 2nd stage milestone ~. OECD/NEA International Workshop on Medical Radioisotopes Supply; 20231016-20; Paris, France.
